It has been found that MIAT facilitated diabetic retinopathy via activating TGF-β1 signaling [32] and induced cardiomyocyte apoptosis in diabetic cardiomyopathy by targeting the miR-22-3p/DAPK2 axis [33]. Here, DAPK2 is linked to diabetic cardiomyopathy.